PNV vs PYC

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

PNV

POLYNOVO FPO [PNV]

53MEDIUM

PYC

PYC THERAP FPO [PYC]

53MEDIUM

Score Breakdown

PNV PYC
Technical
47
60
Catalyst
61
55
Sentiment
50
50
Fundamental
87
42
Momentum
54
75
Risk Gate
35
50

Key Metrics

PNV Metric PYC
$708.1MMarket Cap$1.5B
1.8MAvg Volume (20d)1.1M
+8.6%Short Interest+0.3%
$1.66552-Week High$1.755
$0.86552-Week Low$0.848
-0.3%Daily Change-1.3%
$1.017Reference Price$1.530
+12.5%ROE-47.5%
+7.1%Profit Margin-231.3%

Active Signals

PNV Signals

Knocking on the door of resistance — if it punches through, things could get interesting
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Moderate P/S ratio (5.1x)
Moderate revenue growth (+18%)
Piotroski F-Score strong (8/9, low-confidence approx)
EPS estimates revised upward (+10pts)

PYC Signals

MACD momentum is losing steam
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Beating the Small Ords index — relative strength of 1.23, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Adequate cash runway (7 quarters)
Very high P/S ratio (74.1x)
Revenue in sharp decline (-25%)
Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare PNV and PYC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ACL vs PYC →AVE vs IMC →IMC vs PNV →ACL vs IMC →AVE vs BMT →
PNV Full Analysis → PYC Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).